David Standing

788 total citations
16 papers, 513 citations indexed

About

David Standing is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, David Standing has authored 16 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in David Standing's work include Bioactive Compounds and Antitumor Agents (2 papers), Cancer Mechanisms and Therapy (2 papers) and Advances in Cucurbitaceae Research (2 papers). David Standing is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Cancer Mechanisms and Therapy (2 papers) and Advances in Cucurbitaceae Research (2 papers). David Standing collaborates with scholars based in United States, India and Australia. David Standing's co-authors include Shrikant Anant, Dharmalingam Subramaniam, Prabhu Ramamoorthy, Sivapriya Ponnurangam, Prateek Sharma, Richard J. Battafarano, Shahid Umar, Roy A. Jensen, Prasad Dandawate and Gaurav Kaushik and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

David Standing

16 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Standing United States	11	320	105	104	95	64	16	513
Rishi K. Gara India	12	323 1.0×	84 0.8×	98 0.9×	86 0.9×	31 0.5×	12	594
Ajay Palagani United States	12	243 0.8×	118 1.1×	73 0.7×	69 0.7×	39 0.6×	23	520
Munju Cho South Korea	11	447 1.4×	68 0.6×	123 1.2×	52 0.5×	35 0.5×	14	638
Kirit Pindolia United States	17	347 1.1×	68 0.6×	77 0.7×	168 1.8×	40 0.6×	28	712
Sivapriya Ponnurangam United States	12	414 1.3×	188 1.8×	236 2.3×	104 1.1×	28 0.4×	15	681
Rama P. Ramanujam United States	13	456 1.4×	200 1.9×	350 3.4×	102 1.1×	78 1.2×	20	890
Shengjun Fan China	14	274 0.9×	59 0.6×	53 0.5×	54 0.6×	19 0.3×	19	493
Jia‐Sin Yang Taiwan	17	557 1.7×	241 2.3×	165 1.6×	76 0.8×	20 0.3×	30	855
Binqiang Tian China	11	268 0.8×	91 0.9×	70 0.7×	95 1.0×	14 0.2×	14	497

Countries citing papers authored by David Standing

Since Specialization

Citations

This map shows the geographic impact of David Standing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Standing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Standing more than expected).

Fields of papers citing papers by David Standing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Standing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Standing. The network helps show where David Standing may publish in the future.

Co-authorship network of co-authors of David Standing

This figure shows the co-authorship network connecting the top 25 collaborators of David Standing. A scholar is included among the top collaborators of David Standing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Standing. David Standing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Arnold, Levi, Nathan Farrokhian, Michael J. Barry, et al.. (2025). DCLK1-mediated regulation of invadopodia dynamics and matrix metalloproteinase trafficking drives invasive progression in head and neck squamous cell carcinoma. Molecular Cancer. 24(1). 50–50. 1 indexed citations

Standing, David, Prasad Dandawate, Sumedha Gunewardena, et al.. (2024). Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer. Cell Death and Disease. 15(5). 362–362. 2 indexed citations

Standing, David, et al.. (2024). Role of STAT3 in pancreatic cancer. SHILAP Revista de lepidopterología. 5(1). 20–33. 12 indexed citations

Standing, David, Prasad Dandawate, & Shrikant Anant. (2023). Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies. Frontiers in Endocrinology. 13. 1112987–1112987. 20 indexed citations

Arnold, Levi, David Standing, Subhash Padhyé, et al.. (2023). Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression. SHILAP Revista de lepidopterología. 4(5). 1104–1121. 1 indexed citations

Standing, David, et al.. (2023). The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy. Cancers. 15(9). 2485–2485. 14 indexed citations

Standing, David & Shrikant Anant. (2023). Bypassing the Tollway; a novel path to TLR4 independent stemness regulation. Cancer Letters. 581. 216545–216545. 1 indexed citations

Arnold, Levi, et al.. (2022). Abstract 2419: Understanding the role of DCLK1 mediated invadopodia regulation in HNSCC. Cancer Research. 82(12_Supplement). 2419–2419. 1 indexed citations

Weir, Scott J., Prasad Dandawate, David Standing, et al.. (2021). Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex. Cell Death and Disease. 12(6). 562–562. 11 indexed citations

10.

Dandawate, Prasad, Dharmalingam Subramaniam, David Standing, et al.. (2020). Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway. Scientific Reports. 10(1). 1290–1290. 59 indexed citations

11.

New, Jacob, Dharmalingam Subramaniam, Satish Ramalingam, et al.. (2019). Pleotropic role of RNA binding protein CELF2 in autophagy induction. Molecular Carcinogenesis. 58(8). 1400–1409. 14 indexed citations

12.

Kaushik, Gaurav, Anand Venugopal, Prabhu Ramamoorthy, et al.. (2014). Honokiol inhibits melanoma stem cells by targeting notch signaling. Molecular Carcinogenesis. 54(12). 1710–1721. 67 indexed citations

13.

Kwatra, Deep, Anand Venugopal, David Standing, et al.. (2013). Bitter Melon Extracts Enhance the Activity of Chemotherapeutic Agents Through the Modulation of Multiple Drug Resistance. Journal of Pharmaceutical Sciences. 102(12). 4444–4454. 35 indexed citations

14.

Kwatra, Deep, Dharmalingam Subramaniam, Prabhu Ramamoorthy, et al.. (2013). Methanolic Extracts of Bitter Melon Inhibit Colon Cancer Stem Cells by Affecting Energy Homeostasis and Autophagy. Evidence-based Complementary and Alternative Medicine. 2013. 1–14. 58 indexed citations

15.

Ponnurangam, Sivapriya, et al.. (2013). Tandutinib Inhibits the Akt/mTOR Signaling Pathway to Inhibit Colon Cancer Growth. Molecular Cancer Therapeutics. 12(5). 598–609. 34 indexed citations

16.

Subramaniam, Dharmalingam, Sivapriya Ponnurangam, Prabhu Ramamoorthy, et al.. (2012). Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling. PLoS ONE. 7(2). e30590–e30590. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact